Skip to main content
Screener/Healthcare/Biotechnology

AARD — Aardvark Therapeutics, Inc. Common Stock

NASDAQ
$7.44+2.42 (+48.50%)
Micro CapUnder $10Healthcare
$3.35
$17.94
$5.03
$7.92
EPS (TTM)$-3.21
P/E Ratio-2.12
Dividend Yield—
Market Cap$120.4M
Volume2.51M
Prev Close$5.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$21.6M$-0.99——
Q4 '25$0-$17.6M$-0.81——
Q3 '25$0-$16.3M$-0.75——
Q2 '25$0-$14.4M$-0.66——
Q1 '25$0-$9.3M$-0.43——
Q4 '24$0-$8.8M$-0.40——
Q3 '24$0-$4.2M$-0.20——
Q2 '24$0-$5.4M$-0.25——
Get Your Daily Market Recap